CClinicalTrials.gg
CompletedNCT04618315P-CHATUpdated Mar 6, 2025Results posted

P-CHAT: Comparison of Direct to Consumer Delivery Models for Hearing Devices

An interventional study of Hearing Aids in Hearing Aids and Hearing Loss, sponsored by Northwestern University. Completed at 4 sites in United States. Open to participants aged 50 Years to 79 Years. Per ClinicalTrials.gov, last updated 2025-03-06.

Sponsored by Northwestern University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
584
Allocation
Randomized
Ages
50 Years to 79 Years
Sex
All
01

Study summary

Satisfaction and benefit from hearing aids fit using two patient self fit methods will be compared against those fit using audiology-based best practices. Individuals between the ages of 50 and 79 years of age will be randomly assigned to one of three fitting methods. Benefit and satisfaction will be evaluated six weeks and six months after the initial fitting.

Read the detailed description

Hearing aids are the most pertinent treatment for most adults with hearing loss, a pervasive chronic health problem in \~40% of those over the age of 60 years. Only 20% of these individuals purchase and use hearing aids. The Over-the-Counter Hearing Aid Act of 2017 is designed to increase affordability and accessibility, and thereby adoption, of hearing aids. While this legislation directs the Food and Drug Administration (FDA) to create and administer this new channel of hearing aid provision by 2020, best practices related to hearing aid provision without the involvement of a professional, licensed provider have not been explored and established. Patients do not have the evidence they need to decide between modes of acquiring hearing aids. The current proposal addresses the specific knowledge gap of efficacious direct-to-consumer hearing aid delivery models. Two methods of patient-driven methods of selecting and fitting hearing aids will be compared against audiology-based best practice fitting. Individuals who perceive mild or moderate hearing difficulty will be randomly assigned to one of three fitting arms. Satisfaction and benefit from hearing aids will be assessed at six weeks and six months after initial fit.

02

Conditions studied

  • Hearing Aids
  • Hearing Loss

Browse trials for

03

In context

Hearing Loss

1,092 studies on the registry are indexed under Hearing Loss; 235 are open to participants now.

This study's enrollment of 584 is above the median of 40 across 764 interventional studies indexed under Hearing Loss.

Browse Hearing Loss studies →

Lead sponsor

Northwestern University is the lead sponsor of 1,396 studies on the registry; 199 are open to participants now.

Of its 102 completed or terminated interventional studies of FDA-regulated products, 73 (72%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years to 79 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • 50 - 79 years old.
  • Mild or moderate hearing difficulty.
  • Normal cognition.
  • No prior hearing aid experience.
  • Ability and willingness to pay privately ($650.00) for hearing aids
  • Ability to read and understand English
  • Symmetric hearing loss, no greater than moderate in degree

Exclusion criteria

Exclusion Criteria:

-

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
584 participants (actual)

Study arms

  • Active comparator
    Audiology-Based Best Practice

    Hearing aids will be fit using current best practices used by audiologists to fit hearing aids.

    Device: Hearing Aids

  • Experimental
    Consumer Decides

    Hearing aids will be self fit by patients using an interactive application on a tablet computer. Patients will choose their preferred hearing aid settings after comparing four settings with varying loudness levels.

    Device: Hearing Aids

  • Experimental
    Efficient Fitting

    Hearing aids will be self fit by patients using an interactive application on a tablet computer. Patients will choose their preferred hearing aid settings after comparing four settings with varying base and treble settings.

    Device: Hearing Aids

Interventions

  • DeviceHearing Aids

    Receiver-in-the-ear hearing aids.

06

What researchers measure

Primary outcomes

  1. Profile of Hearing Aid Benefit

    66-item self-assessment, disability-based inventory. Participants answer the questionnaire twice, first prior to use of hearing aids and then after hearing aid use. The questionnaire is scored between 0-99% with higher values representing greater difficulty. Benefit is reported as the difference between the two scores with a higher number signifying greater benefit.

    Time frame: 6 weeks

Secondary outcomes

  1. Hearing Handicap Inventory for the Elderly

    A self-administered scale to identify problems related to hearing loss. The questionnaire has 25 items and can be scored between 0 and 100. The score after hearing aid use is subtracted from the baseline score (prior to hearing aid use) to obtain the benefit score. The higher the difference the greater the benefit.

    Time frame: 6 weeks

Other outcomes

  1. Duration of Hearing Aid Use

    Average hours of hearing aid use per day.

    Time frame: 6 weeks

07

Results

Posted Mar 6, 2025
Limitations and caveats
This study was initiated in 2020 before the approval of OTC hearing aids. Therefore, the devices used may not represent the quality of OTC hearing aids at any given time. The fitting methods used were derived from previous validation studies by the investigators. These results may not be valid for all self-fitting methods used in OTC hearing aids. Finally, the participants enrolled may not represent the demographic distribution of the United States or the areas in which the study was conducted.

Participant flow

6-Week Primary Observation Point
Participant flow — 6-Week Primary Observation Point
MilestoneAudiology-Based Best PracticeConsumer DecidesEfficient Fitting
Started190193201
Completed182172178
Not completed82123
6-Month Secondary Observation Point
Participant flow — 6-Month Secondary Observation Point
MilestoneAudiology-Based Best PracticeConsumer DecidesEfficient Fitting
Started182172178
Completed152132140
Not completed304038

Outcome measures

PrimaryProfile of Hearing Aid Benefit

66-item self-assessment, disability-based inventory. Participants answer the questionnaire twice, first prior to use of hearing aids and then after hearing aid use. The questionnaire is scored between 0-99% with higher values representing greater difficulty. Benefit is reported as the difference between the two scores with a higher number signifying greater benefit.

Time frame:
6 weeks
Reported as:
Mean · score on a scale
Profile of Hearing Aid Benefit
score on a scaleAudiology-Based Best PracticeConsumer DecidesEfficient Fitting
Profile of Hearing Aid Benefit23.34 (21.43 to 25.26)23.27 (21.54 to 25)23.33 (21.25 to 25.12)
SecondaryHearing Handicap Inventory for the Elderly

A self-administered scale to identify problems related to hearing loss. The questionnaire has 25 items and can be scored between 0 and 100. The score after hearing aid use is subtracted from the baseline score (prior to hearing aid use) to obtain the benefit score. The higher the difference the greater the benefit.

Time frame:
6 weeks
Reported as:
Mean · score on a scale
Hearing Handicap Inventory for the Elderly
score on a scaleAudiology-Based Best PracticeConsumer DecidesEfficient Fitting
Hearing Handicap Inventory for the Elderly20.65 (18.11 to 23.19)21.83 (19.42 to 24.23)19.15 (16.59 to 21.73)
Other pre-specifiedDuration of Hearing Aid Use

Average hours of hearing aid use per day.

Time frame:
6 weeks
Reported as:
Mean · hours/day
Duration of Hearing Aid Use
hours/dayAudiology-Based Best PracticeConsumer DecidesEfficient Fitting
Duration of Hearing Aid Use8.42 (7.91 to 8.92)7.18 (6.64 to 7.72)6.83 (6.32 to 7.34)

Adverse events

Collected over 6 months. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Audiology-Based Best Practice0/182 (0%)0/182 (0%)3/182 (1.6%)
Consumer Decides0/172 (0%)0/172 (0%)3/172 (1.7%)
Efficient Fitting0/178 (0%)0/178 (0%)5/178 (2.8%)
Most frequent other events
Most frequent other events
EventAudiology-Based Best PracticeConsumer DecidesEfficient Fitting
Receiver Dome in EarEar and labyrinth disorders2/1822/1724/178
Ear ConditionsEar and labyrinth disorders1/1821/1722/178
TinnitusEar and labyrinth disorders0/1821/1721/178
Reduced HearingEar and labyrinth disorders0/1821/1720/178

Baseline characteristics

Age, Continuous
Age, Continuous(years)Audiology-Based Best PracticeConsumer DecidesEfficient FittingTotal
Mean68.42 ± 6.9569.81 ± 6.7169.1 ± 6.7169.11 ± 6.57
Sex: Female, Male
Sex: Female, Male(Participants)Audiology-Based Best PracticeConsumer DecidesEfficient FittingTotal
Female111104114329
Male798987255
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Audiology-Based Best PracticeConsumer DecidesEfficient FittingTotal
Hispanic or Latino65415
Not Hispanic or Latino184188197569
Unknown or Not Reported0000
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Audiology-Based Best PracticeConsumer DecidesEfficient FittingTotal
American Indian or Alaska Native0000
Asian3137
Native Hawaiian or Other Pacific Islander0000
Black or African American3227
White176187192555
More than one race82212
Unknown or Not Reported0123
Region of Enrollment
Region of Enrollment(participants)Audiology-Based Best PracticeConsumer DecidesEfficient FittingTotal
United States190193201584
Better Ear 4-Frequency (0.5, 1, 2, 4 kHz) Pure Tone Average
Better Ear 4-Frequency (0.5, 1, 2, 4 kHz) Pure Tone Average(dB HL)Audiology-Based Best PracticeConsumer DecidesEfficient FittingTotal
Mean32.1 ± 9.0432.64 ± 9.2131.47 ± 9.0632.06 ± 9.1
Montreal Cognitive Assessment
Montreal Cognitive Assessment(units on a scale)Audiology-Based Best PracticeConsumer DecidesEfficient FittingTotal
Mean26.28 ± 1.9326.18 ± 1.9026.37 ± 1.9626.28 ± 1.93
Hearing Handicap Inventory - Global
Hearing Handicap Inventory - Global(units on a scale)Audiology-Based Best PracticeConsumer DecidesEfficient FittingTotal
Mean39.35 ± 18.8339.66 ± 18.2637.51 ± 19.3738.82 ± 18.82

1 further baseline measures are reported on the registry.

08

Study locations

4 sites
  • Northwestern Memorial Hospital
    Chicago, Illinois 60611, United States
  • Northwestern University Center for Audiology, Speech, Language, and Learning
    Evanston, Illinois 60208, United States
  • Sertoma Speech and Hearing Center
    Palos Hills, Illinois 60465, United States
  • University of Texas Medical Branch
    Galveston, Texas 77555, United States
09

References and documents

Study documents

  • Study protocol · Oct 4, 2024
  • Statistical analysis plan · Oct 18, 2024

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Yes — Data will be shared at the Patient-Centered Outcomes Data Repository

Supporting information: Study protocol, Sap, Icf, Csr, Analytic code

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 6, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT04618315
Lead sponsor
Northwestern University
Responsible party
Sumit Dhar (Professor, Northwestern University) — Principal investigator
First posted
Nov 5, 2020
Start date
Dec 1, 2020
Primary completion
Apr 1, 2024
Completion
Jun 30, 2024
Results posted
Mar 6, 2025
Last update
Mar 6, 2025

Study contacts

Sumitrajit Dhar
principal investigator · Northwestern University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion